News
Upcoming webinar on ototoxicity – 20 January 2022: save the date!
CILcare is pleased to announce that our Global Head of R&D Operations Management, Aurore Marie, will present the latest advances on ototoxicity during the CBSET Talking Tox Webinar as part of ACT's 42nd virtual annual meeting. We are also thrilled to announce the...
CILcare acquires ISO 9001:2015 certification, demonstrating its commitment to quality and customer excellence
Montpellier, November 8th, 2021: CILcare, the world leading CRO specialized in hearing disorders, is proud to announce it has been awarded the ISO 9001:2015 certification for its quality management system that includes the conduct of pharmacokinetics, efficacy,...
Aurore Marie promoted as Global Head, R&D Operations Management, and CILcare’s Board Member
Montpellier, October 13th, 2021: CILcare, the world leading CRO specialized in ear disorders, is pleased of nominating Aurore Marie at the position of Global Head, R&D Operations Management. In her new role, Aurore Marie will drive the support to production...
CILcare will present a valuable diagnostic tool to assess the tolerance of otic products in pets at the 32nd ESVD Congress
CILcare’s team is pleased to announce that the abstract co-written with Virbac, a top 10 animal health company, entitled “Ear inflammation and hearing measurements: taking advantage of preclinical tools to assess the Tolerance of otic products“ has been accepted for...
Replay: Expanding Drug Portfolio in Hearing, with Fast-Track Development Strategies
Do you want to know more about how to leverage pharma discovery engine to accelerate innovation in hearing health? How to develop repurposing and co-developing strategies to rapidly advance promising assets to the market? Find out in the presentation below given by...
BIO Korea 2021 Replay : Noise-induced hearing loss and ageing : physiopathology & strategies for preclinical development
Do you want to learn more on noise-induced hearing loss and ageing? Which strategies can you choose for a successful preclinical development? Find out by watching this presentation given by Dr Wahid Awad, CILcare's Chief Business Officer, at BIO Korea 2021 during a...
CILcare and Knotus partner to accelerate the development of novel therapies to prevent and treat ear disorders in Korean and Asian market
Montpellier & Seoul, June 8th, 2021: CILcare, the world’s leading CRO dedicated to ear disorders, and Knotus, a leading Korean non-clinical CRO, announced today that they have entered into a strategic partnership that aims at accelerating the development of...
CILcare is Sponsoring BIO Korea 2021 & Organizing a Hearing Workshop
BIO Korea is an elite Korean event that gathers experts and academics from the bio industry, not only to present technological information, but mostly to connect innovative actors from the industry to create and discuss opportunities. Taking place on June 9-11 2021,...
